3. Producción
Browse
4 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Simple and low cost alternative method for detecting photoneutrons produced in some radiotherapy treatments using SSNTDs(Elsevier, 2020-07-01)A simple and low cost alternative which is able to identify thermal and fast neutrons in a clinical environment of radiotherapy is presented. CR-39 and LR-115 Solid State Nuclear Track Detectors (SSNTDs) were used, estimating their viability. In order to register alpha tracks due to thermal neutrons, natural boric acid tablets were placed in close contact to the detector, whereas in order to detect epithermal neutrons, some were additionally covered in a thin cadmium layer. Different configurations were assembled, changing the position of the converter with respect to the detector and the incident neutron fluence, which was evaluated in different positions of a radiotherapy table. The contribution due to environmental 222Rn and its daughters to the track density registered by the detector during the measurements was found to be negligible. It is concluded that the designed experimental set up constitutes a trustworthy and affordable method to carry out neutron measurements with the recommended configurations provided for the CR-39 detector, and not with LR-115. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Forgetting other communicable diseases during the COVID-19 pandemic: Tuberculosis mortality in Peru(Elsevier Ltd, 2022-05-01) - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Multimorbidity analysis and hospitalizations for diabetes before and after lockdown due to the COVID-19 pandemic in Peru(Elsevier Inc., 2022-08-01)COVID-19 has disrupted the treatment of non-communicable diseases (NCDs). This study conducted a multimorbidity analysis and evaluated hospital admissions and death rates among diabetic patients before and after the implementation of lockdown due to the COVID-19 pandemic in Peru. Data from the Ministry of Health (MINSA) of Peru from January 2017 to December 2020 was used. Hospital death, discharge and the percentage of death/hospital admissions were defined as outcomes of interest. We performed an interrupted time series analysis to assess the aggregate change in the outcomes of interest before and after mandatory lockdown in response to the COVID-19 pandemic in Peru (n = 65,935). Additionally, a network analysis was performed to evaluate the frequency of occurrence of hospital admissions before and after the mandatory lockdown according to demographic characteristics. The average monthly hospital admissions among diabetic patients in Peru decreased by 29% after the implementation of the lockdown. The largest reduction was observed in women (−41%) and for patients 60 years or older (−35%). Furthermore, there was a 92% increase in the average number of monthly deaths. The largest percentage change occurred in men (+113%) and in the group of 40–59 years (+144%). After the implementation of lockdown in Peru, hospital admissions among diabetic patients significantly decreased while in-hospital mortality slightly increased. Our findings shed light on the limitations of the Peruvian health system and the importance of ensuring continued care of NCDs as part of the response strategy during times of crisis. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos tandem and ovoid applicators in high-dose-rate cervix cancer brachytherapy(Elsevier Inc., 2024-07-01)To compare patient and tumor characteristics, dosimetry, and toxicities between interstitial Syed-Neblett and intracavitary Fletcher-Suit-Delclos Tandem and Ovoid (T&O) applicators in high dose rate (HDR) cervical cancer brachytherapy. METHODS: A retrospective analysis was performed for cervical cancer patients treated with 3D-based HDR brachytherapy from 2011 to 2023 at a single institution. Dosimetric parameters for high-risk clinical target volume and organs at risk were obtained. Toxicities were evaluated using the Common Terminology Criteria for Adverse Events version 5.0. RESULTS: A total of 115 and 58 patients underwent Syed and T&O brachytherapy, respectively. Patients treated with Syed brachytherapy were more likely to have larger tumors and FIGO stage III or IV disease. The median D2cc values to the bladder, small bowel, and sigmoid colon were significantly lower for Syed brachytherapy. Patients treated with Syed brachytherapy were significantly more likely to be free of acute gastrointestinal (44% vs. 21%, p = 0.003), genitourinary (58% vs. 36%, p = 0.01), and vaginal toxicities (60% vs. 33%, p = 0.001) within 6 months following treatment compared to patients treated with T&O applicators. In contrast, Syed brachytherapy patients were more likely to experience late gastrointestinal (68% vs. 49%, p = 0.082), genitourinary (51% vs. 35%, p = 0.196), and vaginal toxicities (70% vs. 57%, p = 0.264). CONCLUSIONS: Syed-Neblett and T&O applicators are suitable for HDR brachytherapy for cervical cancer in distinct patient populations. Acute toxicities are more prevalent with T&O applicators, while patients treated with Syed-Neblett applicators are more likely to develop late toxicities.